8-KRegulation FD

CME GROUP INC. 8-K Report, Regulation FD Disclosure (Nov 13, 2009)

Filed November 13, 2009For Securities:CME

Summary

CME Group Inc. (CME) filed an 8-K on November 13, 2009, primarily to disclose the adoption of prearranged trading plans by its CEO, Craig S. Donohue, and President, Phupinder S. Gill. These plans, structured under Rule 10b5-1, allow the executives to sell shares of CME Group Class A common stock over a 13-month period. This is intended to facilitate orderly portfolio diversification and ensure compliance with company stock ownership guidelines. The Donohue Plan involves the sale of up to 17,500 shares, representing less than 15% of his total holdings, while the Gill Plan involves the sale of up to 6,000 shares, also representing less than 15% of his holdings. The sales will occur at market prices, without executive control over timing, and will be publicly disclosed in accordance with SEC regulations. Both executives currently meet or are on track to meet the company's stock ownership requirements, with Mr. Donohue having met his requirement two years ahead of schedule.

Key Highlights

  • 1CME Group's CEO and President have adopted prearranged stock trading plans (Rule 10b5-1 compliant).
  • 2The plans are designed for orderly diversification of personal investment portfolios.
  • 3CEO Craig S. Donohue will sell up to 17,500 shares over 13 months.
  • 4President Phupinder S. Gill will sell up to 6,000 shares over 13 months.
  • 5These sales represent less than 15% of each executive's current stock holdings.
  • 6Sales will occur at prevailing market prices without executive control over timing.
  • 7All transactions will be publicly disclosed through SEC filings.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose that CME Group's Chief Executive Officer, Craig S. Donohue, and President, Phupinder S. Gill, have adopted prearranged trading plans (under Rule 10b5-1) to sell shares of CME Group Class A common stock. These plans are for orderly portfolio diversification and to comply with company stock ownership guidelines.

No, they are not selling all their shares. The plans involve selling a limited number of shares: up to 17,500 for the CEO and up to 6,000 for the President, which collectively represent less than 15% of each executive's total current holdings, including equity awards.

These stock sales are personal portfolio management decisions by executives and are not directly related to CME Group's operational performance or financial health. The plans are designed to be executed over time and at market prices, with no direct impact on the company's business activities.

CME Group is committed to transparency. All stock sales conducted under these trading plans will be publicly disclosed in accordance with applicable securities laws and regulations through future SEC filings.